Nunes Anne
SEC CIK 1982862 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIK | Anika Therapeutics, Inc. | SVP, Chief Ops Off | 20.7K | — | — | 12 | 2023-10-01 | 2025-03-17 |
Most active insiders at ANIK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Griffin Stephen D. | Pres, CEO, Dir | $149.9K | — |
| 2 | HENNEMAN JOHN B III | Dir | $73.3K | — |
| 3 | Fischetti Gary P | Dir | $41.1K | — |
| 4 | Richard Stephen | Dir | — | — |
| 5 | Colleran David | EVP, GC, Corp Sec | — | — |
| 6 | Capper Joseph H | Dir | — | — |
| 7 | McLeod Ian | SVP, CAO, Treas | — | — |
| 8 | Blanchard Cheryl R | Dir | — | — |
| 9 | CONLEY SHERYL L | Dir | — | — |
Nunes Anne made no open-market trades at ANIK in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-18 | 2025-03-17 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | F - Tax | $15.91 | -1,068 | 20.7K | -5% | -$17.0K |
| D | 2025-03-18 | 2025-03-17 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | M - OptEx | $0.00 | +3,637 | 21.7K | +20% | $0 |
| D | 2025-03-13 | 2025-03-11 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | M - OptEx | $0.00 | +2,561 | 18.8K | +16% | $0 |
| D | 2025-03-13 | 2025-03-11 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | F - Tax | $16.79 | -752 | 18.1K | -4% | -$12.6K |
| D | 2025-03-11 | 2025-03-10 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | M - OptEx | $0.00 | +3,296 | 17.2K | +24% | $0 |
| D | 2025-03-11 | 2025-03-10 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | F - Tax | $16.62 | -959 | 16.3K | -6% | -$15.9K |
| D | 2024-10-04 | 2024-10-01 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | M - OptEx | $0.00 | +2,491 | 14.2K | +21% | $0 |
| D | 2024-10-04 | 2024-10-01 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | F - Tax | $24.27 | -732 | 13.5K | -5% | -$17.8K |
| DM | 2024-03-12 | 2024-03-11 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | F - Tax | $25.58 | -1,720 | 11.1K | -13% | -$44.0K |
| DM | 2024-03-12 | 2024-03-11 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | M - OptEx | $0.00 | +5,856 | 11.8K | +98% | $0 |
| D | 2023-10-03 | 2023-10-01 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | M - OptEx | $0.00 | +2,491 | 5,784 | +76% | $0 |
| D | 2023-10-03 | 2023-10-01 | ANIK | Anika Therapeutics, Inc. | Nunes Anne | SVP, Chief Ops Off | F - Tax | $18.63 | -732 | 5,052 | -13% | -$13.6K |
Purchase Sale Sale after option exercise All abbreviations